TY - JOUR
T1 - Allergic contact dermatitis to topical minoxidil solution
T2 - Etiology and treatment
AU - Friedman, Edward S.
AU - Friedman, Paul M.
AU - Cohen, David E.
AU - Washenik, Ken
PY - 2002/2
Y1 - 2002/2
N2 - After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia. However, some patients present with complaints of pruritus and scaling of the scalp. The most common causes of these symptoms include irritant contact dermatitis, allergic contact dermatitis, or an exacerbation of seborrheic dermatitis. Patients suffering from allergic contact dermatitis may benefit from patch testing to determine the causative allergen. Among the patients we patch tested, propylene glycol was found to be the contactant in a majority of cases, not the minoxidil itself. Many of these patients may be candidates for treatment with alternative formulations using other solvents, such as butylene glycol, polysorbate, or glycerol. Although predictive, patch testing results do not ensure that the compounded preparations will be tolerated. Unfortunately, patients found to be allergic to minoxidil are no longer candidates for topical treatment of their alopecia with any preparations of minoxidil.
AB - After more than a decade of use, topical minoxidil solution has proven to be a safe and effective treatment for androgenetic alopecia. However, some patients present with complaints of pruritus and scaling of the scalp. The most common causes of these symptoms include irritant contact dermatitis, allergic contact dermatitis, or an exacerbation of seborrheic dermatitis. Patients suffering from allergic contact dermatitis may benefit from patch testing to determine the causative allergen. Among the patients we patch tested, propylene glycol was found to be the contactant in a majority of cases, not the minoxidil itself. Many of these patients may be candidates for treatment with alternative formulations using other solvents, such as butylene glycol, polysorbate, or glycerol. Although predictive, patch testing results do not ensure that the compounded preparations will be tolerated. Unfortunately, patients found to be allergic to minoxidil are no longer candidates for topical treatment of their alopecia with any preparations of minoxidil.
UR - http://www.scopus.com/inward/record.url?scp=0036160607&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0036160607&partnerID=8YFLogxK
U2 - 10.1067/mjd.2002.119104
DO - 10.1067/mjd.2002.119104
M3 - Article
C2 - 11807448
AN - SCOPUS:0036160607
SN - 0190-9622
VL - 46
SP - 309
EP - 312
JO - Journal of the American Academy of Dermatology
JF - Journal of the American Academy of Dermatology
IS - 2
ER -